Simple eye-tracking tests on phones or tablets can spot early brain changes and help track progression in multiple sclerosis, offering a low-cost way to improve monitoring and care.
Problems controlling eye movements are common in brain diseases because the parts of the brain that move the eyes can be damaged. Small changes in how people move their eyes — like quick jumps (saccades), looking the wrong way on purpose (anti-saccades), holding gaze steady (fixation), or smoothly following a moving object (smooth pursuit) — can show disease progress before doctors spot symptoms in an exam. These eye movement patterns can help tell apart different types of brain problems, which can guide diagnosis and care. New eye-tracking tools built into phones and tablets can measure these eye movements without bulky machines, making testing easier and cheaper. Because the tests are non-invasive (no needles or scans) and can be done often, they could help doctors notice early worsening of movement or thinking skills and make treatment decisions sooner.
People with MS and their caregivers should care because eye-tracking could give an early warning of changes in the brain that affect walking, thinking, or vision — similar to a smoke alarm that detects small problems before a fire grows. Primary care doctors, nurses, and pharmacists can use these tests to monitor patients more often, helping catch problems between specialist visits. Neurologists and rehabilitation therapists can use the data to personalize treatments, like changing medications or starting physical therapy sooner. Caregivers can use easy phone or tablet tests at home to share clear results with clinicians, which can reduce anxiety and avoid missed signs. Clinics with few specialists can especially benefit because these tools help non-specialist staff safely screen and follow MS patients without expensive equipment.
Most findings come from research and reviews, so more real-world studies are needed to prove how well phone/tablet tests work for people with MS specifically. Eye-tracking can be affected by other things like tiredness, glasses, or eye muscle problems, so results need careful interpretation by a clinician. These tests are a helpful tool, not a replacement for regular medical exams and conversations with your care team.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.